Astrazeneca (AZN) Shares Outstanding (2017 - 2020)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Astrazeneca has reported Shares Outstanding over the past 3 years, most recently at $1.0 billion for Q4 2020.

• For Q4 2020, Shares Outstanding rose 1.3% year-over-year to $1.0 billion; the TTM value through Dec 2020 reached $1.0 billion, up 1.3%, while the annual FY2020 figure was $1.0 billion, 1.3% up from the prior year.
• Shares Outstanding for Q4 2020 was $1.0 billion at Astrazeneca, up from $993.9 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $1.0 billion in Q4 2020 and troughed at $37881.0 in Q4 2018.
• A 3-year average of $667.0 million and a median of $993.9 million in 2019 define the central range for Shares Outstanding.
• Biggest five-year swings in Shares Outstanding: surged 2623755.32% in 2019 and later grew 1.3% in 2020.
• Year by year, Shares Outstanding stood at $37881.0 in 2018, then surged by 2623755.32% to $993.9 million in 2019, then increased by 1.3% to $1.0 billion in 2020.
• Business Quant data shows Shares Outstanding for AZN at $1.0 billion in Q4 2020, $993.9 million in Q4 2019, and $37881.0 in Q4 2018.

Peer Comparison